🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic Patients

Recruitingn/aAges 18 Years - anyAllAl-Nahrain University
NCT06729021 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to evaluate the predictive efficacy of the Modified Caprini Risk Assessment Score and D-Dimer in identifying and managing lower extremity venous thrombosis (LEVT) among cardiothoracic surgery patients in Baghdad. The main questions it aims to answer are: Does combining the Modified Caprini Score with D-Dimer improve the accuracy of predicting lower extremity venous thrombosis (LEVT) compared to using each tool independently? Can these tools effectively guide clinical decisions for lower extremity venous thrombosis (LEVT) prevention and management in this patient population? Participants will: Undergo risk assessment for lower extremity venous thrombosis (LEVT) using the Modified Caprini Score and have their D-Dimer levels measured during their hospital stay. Be monitored for clinical outcomes, including confirmed lower extremity venous thrombos

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Inpatients with a hospital stay over 3 days * Written informed consent obtained from patients or their legal guardians. * Availability for postoperative follow-up to assess outcomes like LEVT development or related complications. Exclusion Criteria: * Preexisting LEVT or Pulmonary Embolism: Diagnosed before the index surgery. * Severe Coagulopathy: Patients with inherited or acquired bleeding disorders (e.g., hemophilia, advanced liver disease). * receiving any anticoagulation therapy for any reason. * patients who did not undergo a postoperative D-dimer test. * Incomplete Data: missing essential clinical or laboratory data for Modified Caprini Score calculation or D-Dimer measurement. * Pregnancy: pregnant women or those within six weeks postpartum. * Noncompliance: Patients unwilling or unable to adhere to study follow-up protocols.
💊

What it tests

  • GCS
  • LMWH
📍

Where

1 site
College of Medicine - Al-Nahrain University
Baghdad, Iraq
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy